Horse chestnut Aescin.Horse Chestnut Extract.

article content dotArticle Content:

product dotProducts Related:Horse Chestnut Extract.

Horse Chestnut Extract Aescin INCI Name Aesculus Hippocastanum Extract EINECS ELINCS No 232-497-7 CAS 8053-39-2.6805-41-0 photo picture image arrowitembigName:Horse Chestnut Extract.
 Serie No:R013.
 Specifications:Aescin 20.0%UV
 INCI Name:AESCULUS HIPPOCASTANUM EXTRACT
 EINECS/ELINCS No.:232-497-7
 CAS:8053-39-2.Aescin 6805-41-0
 Chem/IUPAC Name:Aesculus Hippocastanum Extract is an extract of the horse chestnut, Aesculus hippocastanum, Hippocastanaceae
 Click right photo or button for introduction details of Horse Chestnut Extract.Click for Details

applications dotApplications:

dotarrowrbApplications:

Chronic venous insufficiency.
Leg vein health.
Astringent,anti-inflammatory.
Decongestant,expectorant and tonic.
Leg ulcers and frostbite.
Reduce oedema (swelling with fluid) following trauma.

dotarrowrgProperties:

The unique actions of Horse Chestnut are on the vessels of the circulatory system. It seems to increase the strength and tone of the veinsin particular. It may be used internally to aid the body in the treatment of problems such as phlebitis, inflammation in the veins, varicosity and haemorrhoids.
Dosage:Tincture, 1-4 ml taken three times per day,Powdered extract,300 mg two to three times per day,for up to 12 weeks.

dotarrowsg1Safety and Toxicity:

Acute Toxicity:Escin.LD50-Lethal dose,50 percent kill.Oral.Rodent-rat.833 mg/kg. Details of toxic effects not reported other than lethal dose value.
Allergies:Horse chestnut seed extract (HCSE) may cause an allergic reaction in patients with known allergy to horse chestnuts, esculin,or any of its ingredients (flavonoids, biosides, trisides of quertins, and oligosacharides including 1-ketose and 2-ketose). Anaphylactic shock (severe allergic reaction) has been reported with intravenous (through the vein) use.
Click for Details

Reference:

citations1.Horse chestnut Aescin.Horse Chestnut Extract.

last edit date:21th,May.2009.